|
You are here: Home: BCU Surgeons 2004 Vol 3 Issue 3: Faculty Disclosures
FACULTY DISCLOSURES
As a provider accredited by the ACCME, it is the policy of Research To Practice to require significant financial interest or any other relationship the sponsor or faculty members have with the any commercial product(s) discussed in an educational presentation. The presenting faculty reported the following:
Lori J Pierce, MD |
Peter M Ravdin, MD, PhD |
No financial interests or affiliations to disclose
|
Grants/Research Support: AstraZeneca Pharmaceuticals LP
Consultant: Aventis Pharmaceuticals Inc
|
| Nicholas J Robert, MD |
Richard G Margolese, MD |
Grants/Research Support: Bristol-Myers Squibb Company, Eli Lilly and Company, Genentech BioOncology Consultant and Honorarium: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Genentech BioOncology, Novartis Pharmaceuticals
|
Honorarium: AstraZeneca Pharmaceuticals LP
|
This educational activity contains discussion of published and/or investigational uses of agents that are by the Food and Drug Administration. Research To Practice does not recommend the use of any labeled indications. Please refer to the official prescribing information for each product for discussion indications, contraindications and warnings. The opinions expressed are those of the presenters and construed as those of the publisher or grantor.
|
|
